Global Cell Therapy Market By Overview
Introduction:
Cell Therapy Market was valued at US$ 6.4 Billion in 2024 and is projected to grow at a CAGR of 17.4% to reach US$ 31.9 Billion by 2034.
Cell therapy deals with administration of somatic cells for the treatment of diseases or traumatic damages. The main purpose of the study is to provide long lasting treatment through a single injection of therapeutic cells. Rise in cell therapy transplantations, growing aging patient population, and rising disease awareness globally has driven the growth of the global cell therapy market.
Global Cell Therapy Market By Dynamics
Increase in incidence of diseases
Increase in incidence of diseases such as cancer, cardiac abnormalities, and others are the primary factor driving growth of the global market globally. According to data published by Our World in Data Organization in 2019, 9.6 million people died due to various forms of cancer in 2017. In addition, technological advancements in field of cell therapy and increasing adoption of human cells over animal cells for cell therapeutics research are the key factors boosting growth of the global market. However, stringent government regulations regarding the usage of cell therapy may hamper growth of the global market over the forecast period. Nevertheless, increase in funds for research and surge in number of regulations to promote stem cell therapy in developing countries are expected to create lucrative growth opportunities for the global market over the forecast period.
Global Cell Therapy Market By Segmentation
The cell therapy market is segmented based on clinical-use, type, and region.
Based on clinical-use, the global cell therapy market is segmented into therapeutic area, cell type, non-stem cell therapies, and research-use. The therapeutic area clinical-use segment is further divided into malignancies, muscoskeletal therapies, autoimmune disorders, dermatology, and others. The cell type clinical use segment is further bifurcated into stem cell therapies, BM, blood, & umbilical cord-derived stem cells, adipose derived cells, and others. On the basis of type, the target market is segmented into autologous therapies and allogenic therapies. Autologous therapies type segment is dominating the global market, owing to increasing demand for effective drugs for degenerative and cardic disorders.
Regional Insights:
Based on region the cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold the largest share in the global market over the forecast period, owing to strong regulatory framework for promoting cellular therapy development. In addition, presence of a raft of companies and high cost of therapies in the U.S. are promoting the growth of the regional market. The Asia Pacific market is expected to witness the highest growth over the forecast period, owing to rising investments by developers and consumers in educating themselves for advanced medicinal therapies in emerging economies of this region.
|
Attribute |
Details |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 – 2034 |
|
Market Segmentation |
By Clinical use-Therapeutic Area, Cell Type, Non-Stem Cell Therapies, And Research-Use By Type- Autologous Therapies And Allogenic Therapies |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study the global cell therapy market is segmented based of type, clinical-use, and region.
Active Pharmaceutical Ingredient Market, By Region:
- North America
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
-
- U.S.
- Canada
- Middle East & Africa
Global Cell Therapy Market By Key Players
The key players operating the cell therapy market involves JCR Pharmaceuticals Co. Ltd., Kolon TissueGene, Inc., MEDIPOST, Osiris Therapeutics, Inc., Stemedica Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Anterogen.Co., Ltd., Fibrocell Science, Inc., Vericel Corporation, and PHARMICELL Co., Ltd. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in February 2017, Vericel Corporation conducted first implant of MACI in the U.S. for treatment of symptomatic multiple or single full-thickness cartilage defects of the knee. Further, the company has begun to launch its strategies to increase the number of surgeons employing its products in transplantation procedures.
Global Cell Therapy Market By Company Profile
- JCR Pharmaceuticals Co. Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Kolon TissueGene, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- MediPost
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Osiris Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Stemedica Cell Technologies, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Cells for Cells
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- NuVasive, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- ANTEROGEN.CO., LTD.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Fibrocell Science, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Vericel Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
Global Cell Therapy Market By Table of Contents
Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Clinical-use
- Market Snippet, By Type
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Cell Therapy Market, By Clinical-use, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Therapeutic Area
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Malignancies
- Muscoskeletal Therapies
- Autoimmune Disorders
- Dermatology
- Others
- Cell Type
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- GTT Technology
- 96 System
- Mark III System
- Non-stem Cell Therapies
- Research-use
- Overview
- Global Cell Therapy Market, By Type, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Segment Trends
- Autologous Therapies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Allogenic Therapies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2019 – 2029
- Overview
- Global Cell Therapy Market, By Region, 2019 – 2029, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2019 — 2029
- Y-o-Y Growth Analysis (%), 2019 – 2029
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Clinical-use, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Clinical-use, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Clinical-use, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Clinical-use, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Clinical-use, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Type, 2019 – 2029
- Market Size and Forecast (US$ Mn), By Country, 2019 – 2029
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- JCR Pharmaceuticals Co. Ltd.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Kolon TissueGene, Inc.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- MEDIPOST
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Osiris Therapeutics, Inc.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Stemedica Cell Technologies, Inc.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Cells for Cells
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- NuVasive, Inc.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Anterogen.Co., Ltd.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Fibrocell Science, Inc.
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- Vericel Corporation
- Company Overview
- Clinical-use Portfolio
- Key Highlights
- Financial Overview
- JCR Pharmaceuticals Co. Ltd.
-
- Section
- Research Methodology
- About Us
- Contact
FAQs
The global cell therapy market is segmented based of clinical use, type and region.
Increase in incidence of diseases such as cancer, cardiac abnormalities, and others are the primary factor driving growth of the global market globally.
Based on region the global cell therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to hold the largest share in the global market over the forecast period, owing to strong regulatory framework for promoting cellular therapy development.
The key players operating the global cell therapy market involves JCR Pharmaceuticals Co. Ltd., Kolon TissueGene, Inc., MEDIPOST, Osiris Therapeutics, Inc., Stemedica Cell Technologies, Inc., Cells for Cells, NuVasive, Inc., Anterogen.Co., Ltd., Fibrocell Science, Inc., Vericel Corporation, and PHARMICELL Co., Ltd.